1:20-CV-00793
06/11/2020
Pending - Other Pending
Intellectual Property - Patent
Colm F. Connolly
Gilead Sciences, Inc.
Astellas US LLC
Astellas Pharma US, Inc.
USV Private Limited
Robert M. Oakes
Attorney at Fish & Richardson, P.C.
222 Delaware Avenue, 17Th Floor, P.O. Box 1114
Wilmington, DE 19899-1114
Nitika Gupta Fiorella
Attorney at Fish & Richardson, P.C.
222 Delaware Avenue, 17Th Floor, P.O. Box 1114
Wilmington, DE 19899-1114
Kenneth Laurence Dorsney
Attorney at Morris James LLP
500 Delaware Avenue, Suite 1500
Wilmington, DE 19899-2306
Exhibit A
Exhibit B
Exhibit C
Exhibit D
Civil Cover Sheet
Docket(#11) NOTICE OF SERVICE of (1) USV Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) USV Private Limited's Paragraph 3 Disclosures filed by USV Private Limited.(Dorsney, Kenneth) (Entered: 08/07/2020)
Docket(#10) NOTICE OF SERVICE of Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) (Entered: 07/20/2020)
Docket(#9) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by USV Private Limited. (Dorsney, Kenneth) (Entered: 07/06/2020)
Docket(#8) ANSWER to #1 Complaint, by USV Private Limited.(Dorsney, Kenneth) (Entered: 07/06/2020)
DocketCase Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 06/17/2020)
Docket(#7) SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. USV Private Limited served on 6/12/2020, answer due 7/6/2020. (Oakes, Robert) (Entered: 06/15/2020)
DocketNo Summons Issued. (nmg) (Entered: 06/11/2020)
Docket(#6) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) (Entered: 06/11/2020)
Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) (Entered: 06/11/2020)
Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (nmg) (Entered: 06/11/2020)
Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/13/2020. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 11/13/2022. (nmg) (Entered: 06/11/2020)
Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 06/11/2020)
Docket(#1) COMPLAINT for PATENT INFRINGEMENT filed against USV Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2988296.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(nmg) (Entered: 06/11/2020)
Dig Deeper
Get Deeper Insights on Court Cases